Financial Announcements Archives | Page 71 of 167 | Be Korea-savvy

Archive by category Financial Announcements

Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform

Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform

Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging or previously undruggable disease targets Financing led by 3E Bioventures Capital and Proxima Ventures Ltd. with participation from Lapam Capital Founded by Professor Jun O. Liu of Johns Hopkins University School of Medicine, a pioneer in the molecular [...]

Philips Completes Cancellation of 4.4 Million Shares

Philips Completes Cancellation of 4.4 Million Shares

June 19, 2024, Amsterdam, the Netherlands (Korea Bizwire) – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021. Philips’ current issued [...]

Bedford Metals Announces Financing for $5 Million at $2.25 Per Share

Bedford Metals Announces Financing for $5 Million at $2.25 Per Share

VANCOUVER, British Columbia, June 18, 2024 (Korea Bizwire) – Bedford Metals Corp. (TSX-V: BFM) (the “Company” or “Bedford”) is pleased to announce that it will conduct a non-brokered private placement (the “Financing”) to raise up to $5 million through the offering of up to 2,222,223 common shares at a price of $2.25 per share. The Financing represents [...]

ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)

ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)

A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer.  Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic cancer, measured in patients’ blood using CA19-9 as biomarker, determines survival chances and can be used as a quick way to assess treatment [...]

WillScot Mobile Mini Holdings Announces Pricing of $500 Million Senior Secured Notes Offering

WillScot Mobile Mini Holdings Announces Pricing of $500 Million Senior Secured Notes Offering

PHOENIX, Jun. 13 (Korea Bizwire) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that its indirect subsidiary, Williams Scotsman, Inc. (“WSI”), has priced its offering of $500 million aggregate principal amount of 6.625% senior secured notes due 2029 (the [...]

WillScot Mobile Mini Holdings Announces $500 Million Senior Secured Notes Offering

WillScot Mobile Mini Holdings Announces $500 Million Senior Secured Notes Offering

  PHOENIX, June 13, 2024 (Korea Bizwire) – WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that its indirect subsidiary, Williams Scotsman, Inc. (“WSI”), plans to offer, subject to market and other conditions, $500 million aggregate principal amount of senior [...]

Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials

Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials

– Lead Program, BPT567, will be the first PD1-IL18 immunoconjugate to enter the clinic; Phase 1/2a study in solid tumors expected to begin in 2H 2024 – – Financing led by Johnson & Johnson with participation by new and existing investors – BASEL, Switzerland and SAN DIEGO, June 11, 2024 (Korea Bizwire) – Bright Peak Therapeutics, [...]

Hitachi Energy to Invest Additional $4.5 Billion by 2027 to Accelerate the Clean Energy Transition

Hitachi Energy to Invest Additional $4.5 Billion by 2027 to Accelerate the Clean Energy Transition

Order backlog more than tripled to over $30 billion since 2020 — More than double new investments in manufacturing, engineering, digital, R&D and partnerships across all major markets from 2024 to 2027 — Around $330 million in capacity expansion, modernization, and new build in Sweden, across all product portfolios with additional 2,000 employees — Global [...]

Award-Winning Decision Intelligence Firm Quantexa Accelerates Global Momentum, Announces Strong FY24 Business Results

Award-Winning Decision Intelligence Firm Quantexa Accelerates Global Momentum, Announces Strong FY24 Business Results

Quantexa set to achieve $100M in ARR by end of 2024, fueled by the growing Decision Intelligence Market worth *$500BN New enterprise customers accounted for a 20% (+) contribution to fiscal year ARR Closely coupled enterprise Data and AI strategies see Quantexa’s average contract increase 15% in blended ACV in FY24  LONDON and NEW YORK, [...]

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

DURHAM, N.C., June 04, 2024 (Korea Bizwire) – Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building [...]